|
|
140 West 57th Street, Suite 3B
New York, NY 10019 USA
phone:212.586.2226
fax:212.586.2246
|
|
| Symbol |
Private |
| Exchange |
|
| Founded |
0 |
| Employees |
|
|
|
| www.curetherapeutics.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| In trials with a patch to relieve chronic tendinopathies. |
|
| Management |
| Ronald Burch, MD PhD, CEO; Robert Ang, MD MBA, COO |
| |
|
|
| |
|
| Keywords |
| carpal tunnel syndrome, tennis elbow, transdermal patch, tendonitis, rotator cuff, musculoskeletal, pain management, PainManagement |
|
|
|
| Description |
|
Cure Therapeutics is an early-stage pharmaceutical company dedicated to the development and commercialization of an important new class of nitric oxide-based drugs used to treat musculoskeletal disease. The Hospital for Special Surgery (HSS) in New York City has licensed its nitric oxide technology for use in the development of a topical patch to treat tendon and ligament injuries - conditions such as carpal tunnel syndrome, tennis elbow, and injuries to the rotator cuff and Achilles tendon. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members